On the other hand, treatment of human head and neck squamous cell carcinoma with the anti-BSG monoclonal antibody (CNTO3899) was found to reduce proliferation and induce caspase-mediated apoptosis of cells ex vivo, and to impair tumour growth with increased radio-sensitivity in vivo [168, 169]. Here, BSG is linked to neoplasm.